GLYCOPROTEIN BIOMARKERS FOR ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS AND USES THEREOF

• 1. 食管腺癌和巴雷特食管的糖蛋白生物标志物及其用途 [P] . 中国专利： CN107430126B . 2019.12.06
• 2. 食管腺癌和巴雷特食管的糖蛋白生物标志物及其用途 [P] . 中国专利： CN107430126A . 2017-12-01
• 3. GLYCOPROTEIN BIOMARKERS FOR ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS AND USES THEREOF [P] . US2022018843A1 . 2022-01-20

  机译： 糖蛋白生物标志物用于食管腺癌和Barrett的食道和用途

• 4. GLYCOPROTEIN BIOMARKERS FOR ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS AND USES THEREOF [P] . EP3221701B1 . 2021-03-31

  机译： 糖蛋白生物标志物用于食管腺癌和Barrett的食道和用途

• 5. GLYCOPROTEIN BIOMARKERS FOR ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS AND USES THEREOF [P] . 美国专利： US2019072557A1 . 2019-03-07

  机译： 食管腺癌和巴雷特食管的糖蛋白生物标志物及其用途

• 1. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus [J] . Shah Alok K., Hertel Gunter, Brown Ian, Molecular & cellular proteomics: MCP . 2018,第12期
• 2. Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium [J] . Petrick Jessica L., Li Nan, Anderson Lesley A., Cancer: A Journal of the American Cancer Society . 2019,第23期
• 3. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. [J] . Miller RC, Atherton PJ, Kabat BF, Digestive Diseases and Sciences . 2010,第10期
• 4. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma [C] . Irina Kalatskaya World Organization for Specialized Studies on Diseases of the Esophagus World Congress . 2017
• 5. Signal Transduction in Barrett's Esophagus and Esophageal Adenocarcinoma [D] . Narendran, Nirushan Harushikesh. 2018
• 6. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barretts Esophagus [O] . Alok K. Shah, Gunter Hartel, Ian Brown, 2018
• 7. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers [O] . William M. Grady, Ming Yu, Sanford D. Markowitz, 2020

• 1. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma [J] . Jing Lv ,He-Ping Zhao ,Kun Dai . 世界胃肠病学杂志：英文版 . 2020,第22期
• 2. Biomarkers in Barrett's esophagus and esophageal adenocarcinoma:Predictors of progression and prognosis [J] . Chin-Ann J Ong ,Pierre Lao-Sirieix ,Rebecca C Fitzgerald . 世界胃肠病学杂志：英文版 . 2010,第45期
• 3. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus [J] . Jing Lv ,Lei Guo ,Ji-Han Wang . 世界胃肠病学杂志：英文版 . 2019,第2期
• 4. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma [J] . Jing Lv ,Lei Guo ,Ji-Jun Liu . 世界胃肠病学杂志：英文版 . 2019,第18期
• 5. Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux [J] . Peng Cheng ,Jun Gong ,Tao Wang . 世界胃肠病学杂志：英文版 . 2005,第33期
• 6. 食管——胃交界腺癌、食管腺癌——我国食管癌高发现场面临的是哪一个? [C] . 陈志峰 ,陈万青 ,张思维 . 2009年全国肿瘤登记工作经验交流会 . 2009
• 7. P53、Bcl-2在正常食管黏膜、Barrett食管及食管腺癌中的表达及临床意义 [A] . 肖菲菲 . 2015